- Full Year 2023 MorphoSys AG Earnings Call TranscriptMar 14, 2024€66.04 (-0.39%)Earnings
- MorphoSys AG to be Acquired by Novartis AG Call TranscriptFeb 06, 2024
- MorphoSys AG at JPMorgan Healthcare Conference TranscriptJan 10, 2024
- MorphoSys AG at ASH Meeting and Exposition TranscriptDec 11, 2023
- MorphoSys AG to Discuss MANIFEST-2 Results TranscriptNov 21, 2023
- Q3 2023 MorphoSys AG Earnings Call TranscriptNov 16, 2023€23.35 (-11.22%)Earnings
- MorphoSys AG at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2023
- Half Year 2023 MorphoSys AG Earnings Call TranscriptAug 10, 2023€28.06 (+2.22%)Earnings
- MorphoSys AG Investor Call Focused on Pelabresib TranscriptJun 21, 2023
- MorphoSys AG at Goldman Sachs Healthcare Conference TranscriptJun 13, 2023
- Q1 2023 MorphoSys AG Earnings Call TranscriptMay 04, 2023€20.14 (+8.86%)Earnings
- Full Year 2022 MorphoSys AG Earnings Call TranscriptMar 16, 2023€14.64 (+7.37%)Earnings
- MorphoSys AG at JPMorgan Healthcare Conference TranscriptJan 12, 2023
- Q3 2022 MorphoSys AG Earnings Call TranscriptNov 17, 2022€15 (+4.17%)Earnings
- MorphoSys AG at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2022
- Q2 2022 MorphoSys AG Earnings Call TranscriptAug 04, 2022€22.14 (-2.94%)Earnings
- MorphoSys AG at JMP Securities Life Sciences Conference TranscriptJun 16, 2022
- Q1 2022 MorphoSys AG Earnings Call TranscriptMay 05, 2022€19.29 (-0.87%)Earnings
- Full Year 2021 MorphoSys AG Earnings Call TranscriptMar 17, 2022€24.56 (+2.59%)Earnings
- MorphoSys AG at JPMorgan Healthcare Conference TranscriptJan 12, 2022
- Q3 2021 MorphoSys AG Earnings Call TranscriptNov 11, 2021€37.39 (-2.63%)Earnings
- MorphoSys AG at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 13, 2021
- MorphoSys AG at Citi BioPharma Conference (Virtual) TranscriptSep 09, 2021
- Half Year 2021 MorphoSys AG Earnings Call TranscriptJul 29, 2021€47.34 (+4.85%)Earnings
- MorphoSys AG To Acquire Constellation Pharmaceuticals M&A Call TranscriptJun 02, 2021
- MorphoSys AG at UBS Global Healthcare Virtual Conference TranscriptMay 25, 2021
- Q1 2021 MorphoSys AG Earnings Call TranscriptMay 06, 2021€72.5 (+2.06%)Earnings
- Full Year 2020 MorphoSys AG Earnings Call TranscriptMar 16, 2021€75.02 (-10.61%)Earnings
- MorphoSys AG at JPMorgan Healthcare Conference (Virtual) TranscriptJan 13, 2021
- Q3 2020 MorphoSys AG Earnings Call TranscriptNov 12, 2020€88.16 (-1.17%)Earnings
- MorphoSys AG and Incyte Corp to Discuss the Unmet Need and Global Opportunities for Tafasitamab in Non-Hodgkin Lymphomas Investor Call TranscriptSep 29, 2020
- Half Year 2020 MorphoSys AG Earnings Call TranscriptAug 06, 2020€109.8 (-5.26%)Earnings
- MorphoSys AG at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 10, 2020
- Q1 2020 MorphoSys AG Earnings Call TranscriptMay 07, 2020€113 (+10.46%)Earnings
- Full Year 2019 MorphoSys AG Earnings Call TranscriptMar 19, 2020€72.2 (+2.85%)Earnings
- MorphoSys AG at JPMorgan Healthcare Conference TranscriptJan 15, 2020
- MorphoSys AG and Incyte Sign Global Collaboration and License Agreement for Tafasitamab Conference Call TranscriptJan 13, 2020
- Q3 2019 Morphosys AG Earnings Call TranscriptOct 30, 2019€99.1 (+4.21%)Earnings
- Half Year 2019 Morphosys AG Earnings Call TranscriptAug 07, 2019€109 (+4.81%)Earnings
- Morphosys AG To Discuss Results From The Primary Analysis Of The Ongoing Single-Arm Phase 2 Clinical Trial L-MIND Conference Call TranscriptMay 20, 2019
- Q1 2019 Morphosys AG Earnings Call TranscriptMay 08, 2019€95.4 (+5.41%)Earnings
- Full Year 2018 Morphosys AG Earnings Call TranscriptMar 14, 2019€87.05 (+0.23%)Earnings
MorphoSys AG at ASH Meeting and Exposition Transcript
Good morning, good afternoon, ladies and gentlemen. Thank you for standing by. Welcome, and thank you for joining the ASH 2023 Investor Event with MorphoSys Management and Medical Experts. Throughout today's recorded presentation, (Operator Instructions). Been my pleasure to turn the conference over to Julia Neugebauer. Please go ahead, ma'am.
Thank you. Yes. Welcome, everybody. Welcome to those who are in the room and also welcome to those who are on the webcast. A quick reminder, we will be making forward-looking statements, so we ask you to please have a look at Slide 2 of our presentation. Also, all comments we make today speak as of today.
And with that, we can get started, and I hand it over to Jean-Paul.
Thanks, Julia. Good morning, everyone, big ASH for us at MorphoSys, I hope you could attend the session yesterday, which was actually very well attended. We had a
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)